iFAST Diagnostics is addressing the $4bn Antimicrobial Susceptibility Testing (AST) market.
iFAST have developed a low cost, high throughput test delivering results in 3-4 hours from a positive blood bottle or a raw urine sample, saving lives and reducing the spread of antimicrobial resistance.